Live news related to IBA stock (BE0003766806): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on IBA mainly cover M&A activity. The stock trades at €16,42 on Euronext Paris, up 2,11% at the last update. This page lists the articles published on IBA stock to track the share price, company announcements and any item likely to influence market perception.
IBA has announced that its contract signed in April with the Portuguese Institute of Oncology of Porto (IPO-Porto) has come into effect following appr…
IBA signed a contract on Thursday with the Fundação Severino Sombra (FUSVE), a Brazilian non-profit institution, to set up a Proteus One system in Rio…
IBA announces a reorganization of its executive responsibilities. Olivier Legrain, who has led the company since 2012, becomes Vice-Chairman of the Bo…
On Wednesday, IBA signed a sponsored research agreement with the University of Texas MD Anderson Cancer Center, aiming to generate robust clinical and…
IBA announced on Monday the signing of a contract with Duke University Health System for the installation of two Proteus One proton therapy solutions …
IBA (Ion Beam Applications) announced on Monday the launch of Cyclone iKure, a cyclotron dedicated to the clinical-scale production of Astatine-211. T…
The stock of Belgian proton therapy specialist IBA marked a significant increase of 5.11% by midday on Monday, December 29, reaching 12.76 euros from …
IBA shares saw a significant rise this Thursday, November 20, at mid-session, driven by the publication of its third-quarter results and the announcem…
